SureTrader Advertisement Advertisement
Home > Boards > US Listed > Medical - Drugs >

Arbutus Biopharma Corporation (ABUS)

Add ABUS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator mick, nanopatent, KarinCA
Search This Board:
Last Post: 10/13/2015 3:58:20 PM - Followers: 107 - Board type: Free - Posts Today: 1

Arbutus Biopharma Corporation







Company Information:

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8

Telephone: 604.419.3200
Fax: 604.419.3201


As the fields of genetics, medicine and therapeutics continue to converge, the management of illness at its genetic source by silencing genes via RNA interference (RNAi) holds the very real potential to revolutionize treatment on a scale not seen in decades. Tekmira is one of a handful of biotech companies around the world working to exploit the potential of RNAi to treat disease. And it is from among these unique companies that the next wave of therapeutic breakthroughs will emerge.

 Tekmira is uniquely equipped to become a leading force in the field. Guided by a cohesive vision, the company possesses leading technology capabilities and a solid intellectual property portfolio in the area of lipid-based nucleic acid delivery, known as SNALP (Stable Nucleic Acid Lipid Particles) to deliver siRNAs (small interfering RNAs) as well as other oligonucleotides in the treatment of disease.

With one RNAi drug candidate in clinical development and another in late preclinical development,  plus a pipeline of up to five additional targets made possible through an agreement with RNAi leader Alnylam, Tekmira is well positioned to aggressively advance its product development strategy. In addition to Alnylam, Roche, Merck and Regulus all have access to Tekmira's technology in the delivery of siRNAs and microRNAs.

Finally, broad manufacturing capabilities and a strong capital position permit the company to move forward decisively and build a solid base for both near and longer term growth.




Important Company Highlights: 

LNP Delivery Platform

Tekmira’s Lipid Nanoparticle (LNP) technology represents the most widely adopted RNAi delivery technology to date. Administered intravenously, our LNP delivery technology allows RNAi drugs to be encapsulated in tiny particles made of lipids (fats or oils). These tiny particles – LNP – travel through the bloodstream to target tissues.





Recent News:





Links of importance for those that trade Canadian stocks:




 CNW Group Newswire:

Canadian Insider:

Currency Converter:


Transfer Agent:

CIBC Mellon Trust,
Suite 1600, The Oceanic Plaza,
1066 West Hastings Street,
Vancouver, BC V6E 3X1

Share Structure:   See filings

Investor Relations:

Ian Mortimer
Executive Vice President, Finance and Chief Financial Officer
Telephone: 604.419.3200
Fax: 604.419.3201

Adam Peeler
Investor Relations
The Equicom Group
Telephone: 416.815.0700 x 225 

 Currency Converter:

Five Year Weekly Chart





 All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ABUS News: Current Report Filing (8-k) 10/06/2015 08:31:37 AM
ABUS News: Arbutus Biopharma Presents Preclinical Data at the 2015 International Meeting on Molecular Biology of Hepatitis B Viruses 10/06/2015 08:30:00 AM
ABUS News: Current Report Filing (8-k) 10/01/2015 10:01:23 AM
ABUS News: Arbutus to Present TKM-HBV Data at the 2015 AASLD Liver Meeting 10/01/2015 10:00:00 AM
ABUS News: Arbutus to Present at the Baird 2015 Healthcare Conference 09/21/2015 08:46:10 PM
#4953  Sticky Note NEW COMPANY NAME/ ARBUTUS BIOPHARMA CORPORATION/ $ABUS recent news/filings[/b mick 08/06/15 01:42:07 PM
#4993 mick 10/13/15 03:58:20 PM
#4992   is ABUS finally ready to start a move rivervalley 10/09/15 10:08:17 AM
#4991   That would require knowledge and review beyond my nanopatent 10/08/15 10:48:13 PM
#4990   Nano patent Are there any impingements on TKMR patents? Echo 20 Echo20 10/08/15 05:24:04 PM
#4989   Novel targeted siRNA-loaded hybrid nanoparticles: preparation, characterization nanopatent 10/08/15 05:07:20 PM
#4988   Nano patent The previous post sounds familiar. Echo 20 Echo20 10/08/15 03:13:55 PM
#4987   Nano patent The cure for aging gave you cancer. But Echo20 10/08/15 02:45:03 PM
#4986   Nano patent I just read a report that found Echo20 10/08/15 01:47:08 PM
#4985   Results of Search in US Patent Collection db for: nanopatent 10/08/15 01:16:42 PM
#4984   Nano patent I just read a report that found Echo20 10/08/15 01:07:22 PM
#4983 mick 10/05/15 02:02:25 AM
#4982   IBB up over 4% currently this morning, and rivervalley 09/30/15 10:13:10 AM
#4981 mick 09/26/15 03:54:14 PM
#4980   good deal, one I have in this sector rivervalley 09/24/15 02:32:42 PM
#4979   Did anything come from that $140 million DoD nanopatent 09/21/15 06:34:53 PM
#4978   Most look like increased government funding on some KarinCA 09/21/15 04:31:33 PM
#4977   Form CT ORDER - Confidential treatment order filed 21sept15 KarinCA 09/21/15 03:54:45 PM
#4976   HOD 7.72, finally making a move back up rivervalley 09/17/15 03:14:07 PM
#4975   7.35 HOD so far this morning. Its a start. rivervalley 09/17/15 09:52:04 AM
#4974 mick 09/14/15 02:10:49 PM
#4973   Arbutus Biopharma Co (ABUS) mick 09/12/15 04:47:59 PM
#4972   added some shares today and dropped my ave rivervalley 09/10/15 03:15:26 PM
#4971   vol seems to be tapering off the last rivervalley 09/10/15 03:03:00 PM
#4970   well for me anyways its more than just rivervalley 09/09/15 02:49:27 PM
#4969   i have not bought this dip yet/ something mick 09/09/15 11:43:29 AM
#4968   so I take it you never bought in? rivervalley 09/09/15 09:16:17 AM
#4967   since merger nothing but downtrend. links ????? mick 09/04/15 10:48:07 AM
#4966   are you in? out? I see some links rivervalley 09/03/15 09:31:59 PM
#4965 mick 09/02/15 08:09:09 PM
#4964 mick 08/25/15 01:03:51 PM
#4963   Haven't played any otc stocks for a long rivervalley 08/20/15 03:28:50 PM
#4962   ABUS can bottom any time now..... rivervalley 08/17/15 10:08:37 AM
#4961 mick 08/08/15 05:39:05 PM
#4960   Nano patent Would you tell that to the Marines? Echo20 Echo20 08/07/15 03:40:45 PM
#4959   Is this heading for $1.22? Rawnoc 08/07/15 02:43:13 PM
#4957   I think that Ebola stuff was a dud nanopatent 08/07/15 01:06:29 PM
#4956   Nano patent Tkmr could have done the RING approach. Maybe Echo20 08/07/15 12:38:57 PM
#4955   make that 3,000 now at 10.20 :) rivervalley 08/06/15 04:15:15 PM
#4954   a couple thousand shares at 10.20 in ah session. rivervalley 08/06/15 04:14:26 PM
#4953   NEW COMPANY NAME/ ARBUTUS BIOPHARMA CORPORATION/ $ABUS recent news/filings[/b mick 08/06/15 01:42:07 PM
#4952   ONE RECENT CASE YESTERDAY/ EBOLA mick 08/06/15 01:34:07 PM
#4951 mick 08/06/15 01:32:05 PM
#4950   Yup - new name, new products, new strategy. nanopatent 08/05/15 02:00:25 PM
#4949   Nano patent Arbutus? Echo20 Echo20 08/05/15 12:53:34 PM
#4948   picked up a few 10.50's today on the rivervalley 08/04/15 02:18:07 PM
#4947   some nice buys rolling in now. rivervalley 08/04/15 11:22:50 AM
#4946   Tekmira name and symbol change effective today KarinCA 08/03/15 10:57:45 AM
#4945   Confidential Treatment Order (ct Order) nanopatent 07/31/15 01:09:07 PM
#4944   green start to the day. Hope it continues rivervalley 07/31/15 10:21:24 AM
#4943   Sadly no mention of TKM Ebola Ron1303 07/31/15 08:15:01 AM